AAPL   366.27 (+0.59%)
MSFT   207.10 (+1.17%)
FB   233.87 (-1.55%)
AMZN   2,897.95 (+0.67%)
NVDA   385.90 (+1.23%)
CGC   16.56 (+0.55%)
GE   6.84 (+1.48%)
TSLA   1,210.92 (+8.15%)
AMD   52.43 (-0.30%)
T   30.16 (+0.84%)
GILD   76.52 (+0.60%)
DIS   112.54 (-0.42%)
NFLX   479.73 (-1.22%)
BA   181.14 (+0.45%)
AAPL   366.27 (+0.59%)
MSFT   207.10 (+1.17%)
FB   233.87 (-1.55%)
AMZN   2,897.95 (+0.67%)
NVDA   385.90 (+1.23%)
CGC   16.56 (+0.55%)
GE   6.84 (+1.48%)
TSLA   1,210.92 (+8.15%)
AMD   52.43 (-0.30%)
T   30.16 (+0.84%)
GILD   76.52 (+0.60%)
DIS   112.54 (-0.42%)
NFLX   479.73 (-1.22%)
BA   181.14 (+0.45%)
AAPL   366.27 (+0.59%)
MSFT   207.10 (+1.17%)
FB   233.87 (-1.55%)
AMZN   2,897.95 (+0.67%)
NVDA   385.90 (+1.23%)
CGC   16.56 (+0.55%)
GE   6.84 (+1.48%)
TSLA   1,210.92 (+8.15%)
AMD   52.43 (-0.30%)
T   30.16 (+0.84%)
GILD   76.52 (+0.60%)
DIS   112.54 (-0.42%)
NFLX   479.73 (-1.22%)
BA   181.14 (+0.45%)
AAPL   366.27 (+0.59%)
MSFT   207.10 (+1.17%)
FB   233.87 (-1.55%)
AMZN   2,897.95 (+0.67%)
NVDA   385.90 (+1.23%)
CGC   16.56 (+0.55%)
GE   6.84 (+1.48%)
TSLA   1,210.92 (+8.15%)
AMD   52.43 (-0.30%)
T   30.16 (+0.84%)
GILD   76.52 (+0.60%)
DIS   112.54 (-0.42%)
NFLX   479.73 (-1.22%)
BA   181.14 (+0.45%)
Log in

NYSEAMERICAN:MLSSMilestone Scientific Stock Price, Forecast & News

$1.99
+0.05 (+2.58 %)
(As of 07/2/2020 03:42 PM ET)
Add
Compare
Today's Range
$1.91
Now: $1.99
$1.99
50-Day Range N/A
52-Week Range
$0.37
Now: $1.99
$3.05
Volume17,657 shs
Average Volume491,080 shs
Market Capitalization$110.39 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances. CompuFlo also includes a disposable injection handpiece for the tactile control during the injection; CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; CompuMed for use in various applications, such as plastic, hair restoration, podiatry, colorectal, dermatology, orthopedics, and various other surgeries. Its products also comprising Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin; Veterinary Nerve Block Anesthesia device; the Wand Single Tooth Anesthesia System; and other devices. Milestone Scientific, Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.20 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:MLSS
CUSIPN/A
Phone+1-973-5352717

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees16
Market Cap$110.39 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive MLSS News and Ratings via Email

Sign-up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter.

Milestone Scientific (NYSEAMERICAN:MLSS) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Milestone Scientific?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Milestone Scientific in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Milestone Scientific.

When is Milestone Scientific's next earnings date?

Milestone Scientific is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Milestone Scientific.

How were Milestone Scientific's earnings last quarter?

Milestone Scientific Inc. (NYSEAMERICAN:MLSS) posted its quarterly earnings data on Friday, May, 15th. The medical instruments supplier reported ($0.03) earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $1.81 million for the quarter. View Milestone Scientific's earnings history.

What price target have analysts set for MLSS?

1 brokers have issued 12 month price objectives for Milestone Scientific's shares. Their forecasts range from $4.00 to $4.00. On average, they expect Milestone Scientific's share price to reach $4.00 in the next year. This suggests a possible upside of 101.0% from the stock's current price. View analysts' price targets for Milestone Scientific.

Has Milestone Scientific been receiving favorable news coverage?

News coverage about MLSS stock has been trending very negative this week, InfoTrie reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Milestone Scientific earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Milestone Scientific.

Are investors shorting Milestone Scientific?

Milestone Scientific saw a drop in short interest in the month of June. As of June 15th, there was short interest totaling 1,340,000 shares, a drop of 6.3% from the May 31st total of 1,430,000 shares. Based on an average daily trading volume, of 390,700 shares, the short-interest ratio is currently 3.4 days. Currently, 3.7% of the shares of the stock are short sold. View Milestone Scientific's Current Options Chain.

Who are some of Milestone Scientific's key competitors?

What other stocks do shareholders of Milestone Scientific own?

Who are Milestone Scientific's key executives?

Milestone Scientific's management team includes the following people:
  • Mr. Leonard A. Osser, Founder, Interim CEO & Director (Age 72)
  • Mr. Joseph D'Agostino CPA, CPA, CFO & COO (Age 67)
  • Ms. Sharon Smith, Exec. VP of Global Sales & Marketing
  • Mr. Gian Domenico Trombetta, Pres & CEO of Wand Dental Inc. and Director (Age 58)
  • Mr. James McAvinn, Sr. VP of Sales & Marketing

What is Milestone Scientific's stock symbol?

Milestone Scientific trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MLSS."

How do I buy shares of Milestone Scientific?

Shares of MLSS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Milestone Scientific's stock price today?

One share of MLSS stock can currently be purchased for approximately $1.99.

How big of a company is Milestone Scientific?

Milestone Scientific has a market capitalization of $110.39 million. Milestone Scientific employs 16 workers across the globe.

What is Milestone Scientific's official website?

The official website for Milestone Scientific is www.milesci.com.

How can I contact Milestone Scientific?

Milestone Scientific's mailing address is 220 S Orange Ave, LIVINGSTON, NJ 07039-5804, United States. The medical instruments supplier can be reached via phone at +1-973-5352717.

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.